Saturday, November 23, 2024
HomeTagsInvestigational New Drug

Investigational New Drug

Egret Therapeutics Receives FDA Clearance of IND Application for EGT 101 for Treatment of Delayed Cerebral Ischemia

Egret Therapeutics, a clinical-stage biotechnology company focused on developing transformative therapies for neurological conditions, announced that the U.S. Food and Drug Administration (FDA) has...

Deka Biosciences, Inc Announces of Investigational New Drug (IND) Application

Deka Biosciences, Inc. (Deka), a biotech company focused on developing novel cytokine therapies to treat cancer and inflammatory diseases, announced the submission of an...

Ascletis Announces U.S. IND Filing of Oral 3CLpro Inhibitor ASC11 for COVID-19

Ascletis Pharma Inc. announces that the Investigational New Drug (IND) application of ASC11, an oral inhibitor drug candidate targeting 3-chymotrypsin like protease (3CLpro) for...

FDA Clears SNIPR BIOME’s Investigational New Drug Application for SNIPR001, Targeting E. coli Infections

SNIPR BIOME ApS, a leading CRISPR and microbiome biotechnology company, is pleased to announce that the US Food and Drug Administration (FDA) has approved...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics